Jenna Kawamoto
Overview
Explore the profile of Jenna Kawamoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
48
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen P, Truong J, Kawamoto J, Bhattacharya D, Patel A
Fed Pract
. 2024 Jun;
41(3):88-92.
PMID: 38835674
Introduction: The COVID-19 pandemic has presented challenges for hepatitis C virus (HCV) treatment given the need for thorough evaluation by specialists, treatment coordination, follow-up visits, laboratory monitoring, and potential health...
2.
Cameron M, Kawamoto J, Shahoumian T, Belperio P
Fed Pract
. 2023 Oct;
40(7):218-223.
PMID: 37868711
Background: Uptake and access to HIV preexposure prophylaxis (PrEP) is key to reducing incident HIV infections. Pharmacists are one of the most accessible health care professionals in the United States...
3.
Bangaru S, Sundaresh R, Lee A, Prause N, Hao F, Dong T, et al.
Dig Dis Sci
. 2023 Oct;
68(12):4474-4484.
PMID: 37864738
Background And Aims: Nonalcoholic fatty liver disease (NAFLD) has reached pandemic proportions. Early detection can identify at-risk patients who can be linked to hepatology care. The vibration-controlled transient elastography (VCTE)...
4.
Mohtashemi N, Teng C, Benhammou J, Dong T, Goetz M, Patel A, et al.
Sci Rep
. 2023 Oct;
13(1):17241.
PMID: 37821437
A Hepatitis C (HCV) e-Consult Direct-To-Treatment (DTT) program managed by midlevel providers was developed at the Veteran Affairs Greater Los Angeles Healthcare System (VAGLAHS) which provided remote referral and, in...
5.
Aby E, Winters A, Lin J, Bui A, Kawamoto J, Goetz M, et al.
Hepatol Commun
. 2020 Jun;
4(6):825-833.
PMID: 32490319
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide. Society guidelines recommend surveillance with abdominal ultrasound with or without serum alpha-fetoprotein every 6 months for adults at increased...
6.
Bakr O, Gelberg L, Seragaki S, Youn S, Kawamoto J, Hoppe M, et al.
Hepatology
. 2019 Apr;
70(3):1071-1073.
PMID: 30945758
No abstract available.
7.
Dong T, Aby E, Benhammou J, Kawamoto J, Han S, May F, et al.
World J Hepatol
. 2018 Oct;
10(9):612-621.
PMID: 30310539
Aim: To determine whether successful treatment with directacting antivirals (DAA) is associated with improvements in hemoglobin A1c (HbA1c) and if type 2 diabetes mellitus (T2DM) or metabolic syndrome affects sustained...
8.
Benhammou J, Dong T, May F, Kawamoto J, Dixit R, Jackson S, et al.
Pharmacol Res Perspect
. 2018 Feb;
6(2):e00379.
PMID: 29484189
Hepatitis C virus (HCV) infection is a major cause of chronic liver disease. HCV cure has been linked to improved patient outcomes. In the era of direct-acting antivirals (DAAs), HCV...
9.
Aby E, Dong T, Kawamoto J, Pisegna J, Benhammou J
World J Hepatol
. 2018 Jan;
9(36):1352-1360.
PMID: 29359019
Aim: To determine how sustained virological response at 12 wk (SVR12) with direct acting antivirals (DAAs) for the treatment of hepatitis C virus (HCV) infection affects chronic kidney disease (CKD)...
10.
You A, Kawamoto J, Smith J
J Telemed Telecare
. 2014 Jan;
20(2):99-101.
PMID: 24414398
We established a pharmacist-led telemedicine clinic to manage patients with chronic hepatitis C infection. The clinic used individual pharmacist-to-patient consultations. There was also a group hepatitis C patient education class....